Sweet syndrome associated with moderate leukocyte adhesion deficiency type I: a case report and review of the literature
- PMID: 39081307
- PMCID: PMC11286406
- DOI: 10.3389/fimmu.2024.1425289
Sweet syndrome associated with moderate leukocyte adhesion deficiency type I: a case report and review of the literature
Abstract
Sweet syndrome is an acute febrile neutrophilic dermatosis characterized by the infiltration of neutrophils into the skin. It may occur idiopathically or be linked to malignancies, inflammatory or autoimmune diseases. Leukocyte adhesion deficiency type I (LAD-I) is an inborn error immunity wherein leukocytes lack adhesion molecules necessary for migration to infection sites due to mutations in the CD18 gene encoding β2 integrins. We present a case of a 16-month-old female initially diagnosed and treated for Sweet syndrome based on histopathological findings with recurrent flare episodes. Subsequent workup revealed LAD-I, making this case the first documented association between Sweet syndrome and LAD-I. Moreover, we reviewed the pertinent literatures detailing the concurrence of neutrophilic dermatosis and immunodeficiency disorders. This case underscores the significance of comprehensive evaluation for Sweet syndrome patients who are refractory to conventional treatments.
Keywords: inborn error of immunity (IEI); leukocyte adhesion deficiency type 1; neutrophilic dermatosis; sweet syndrome; whole exome sequencing.
Copyright © 2024 Saito, Kewalramani, Peng, Magnarelli and Lederman.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Clinical and Genetic Spectrum of a Large Cohort of Patients With Leukocyte Adhesion Deficiency Type 1 and 3: A Multicentric Study From India.Front Immunol. 2020 Dec 16;11:612703. doi: 10.3389/fimmu.2020.612703. eCollection 2020. Front Immunol. 2020. PMID: 33391282 Free PMC article.
-
Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins.J Clin Invest. 1997 Oct 1;100(7):1725-33. doi: 10.1172/JCI119697. J Clin Invest. 1997. PMID: 9312170 Free PMC article.
-
Molecular characterization of leukocyte adhesion deficiency-I in Indian patients: identification of 9 novel mutations.Blood Cells Mol Dis. 2015 Mar;54(3):217-23. doi: 10.1016/j.bcmd.2015.01.012. Epub 2015 Jan 23. Blood Cells Mol Dis. 2015. PMID: 25703682
-
Hematologically important mutations: leukocyte adhesion deficiency (first update).Blood Cells Mol Dis. 2012 Jan 15;48(1):53-61. doi: 10.1016/j.bcmd.2011.10.004. Epub 2011 Nov 30. Blood Cells Mol Dis. 2012. PMID: 22134107 Free PMC article. Review.
-
Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands.Curr Opin Hematol. 2002 Jan;9(1):30-5. doi: 10.1097/00062752-200201000-00006. Curr Opin Hematol. 2002. PMID: 11753075 Review.
References
-
- Opalinska A, Burdacki A, Kwasniak K. Pyoderma gangrenosum with an underlying leukocyte adhesion deficiency type 1 (LAD-1) and pregnancy in the shade of COVID-19 epidemic: a patient and physician experience. Dermatol Ther (Heidelb). (2021) 11:643–53. doi: 10.1007/s13555-021-00507-x - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources